Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY24.18 CNY
Change Today -0.83 / -3.32%
Volume 12.3M
600297 On Other Exchanges
As of 3:05 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

merro pharmaceutical co lt-a (600297) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/27/15 - CNY28.49
52 Week Low
06/25/14 - CNY7.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MERRO PHARMACEUTICAL CO LT-A (600297)

Related News

No related news articles were found.

merro pharmaceutical co lt-a (600297) Related Businessweek News

No Related Businessweek News Found

merro pharmaceutical co lt-a (600297) Details

Merro Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceutical products in China. It primarily offers chemical, biological, Chinese traditional, and herbal medicines. The company’s products include amifostine injections for use as antineoplastic; pantoprazole sodium injections and capsules for the treatment of ulcer; and roxithromycin tablets, and azithromycin tablets and injections for use as antibiotics. Its products also comprise azelastine hydrochloride tablet for antiallergy; guaifensin and dextromethorphan hydrobromide tablets for the treatment of codeine; and famciclovir capsules for the treatment of herpes. The company offers its products under Amifostine, WeiKe'an, Xinmeiluo, Xinbaike, Ketan, Xianlinna, and Aimiqi brands. Merro Pharmaceutical Co., Ltd. was founded in 1925 and is headquartered in Dalian, China.

Founded in 1925

merro pharmaceutical co lt-a (600297) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

merro pharmaceutical co lt-a (600297) Key Developments

Merro Pharmaceutical Co.,Ltd., Board Meeting, May 12, 2015

Merro Pharmaceutical Co.,Ltd., Board Meeting, May 12, 2015. Agenda: To discuss and approve the proposal of convening online performance meeting in 2014; and to approve the proposal of convening annual general meeting of 2014.

Merro Pharmaceutical Co.,Ltd. to Report Q1, 2015 Results on Apr 30, 2015

Merro Pharmaceutical Co.,Ltd. announced that they will report Q1, 2015 results on Apr 30, 2015

Merro Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Quarter of 2015

Merro Pharmaceutical Co.,Ltd. announced earnings results for the first quarter of 2015. For the quarter, the company's basic earnings per share were CNY 0.0105 and weighted average return on net assets was 0.3827%.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600297:CH CNY24.18 CNY -0.83

600297 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600297.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600297 Industry Range
Price/Earnings 100.0x
Price/Sales 23.3x
Price/Book 8.8x
Price/Cash Flow 246.3x
TEV/Sales 22.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRO PHARMACEUTICAL CO LT-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at